Effect of ligand of peroxisome proliferator-activated receptor γ on the biological characters of hepatic stellate cells

Figure 1 PPARγ mRNA level. A: Expression of PPARγ mRNA. Lane 1, 10 µmol/L rosiglitazone group; lane 2, 3 µmol/L rosiglitazone group; lane 3, control group; B: Expression of β-actin.

Figure 2 PPARγ protein was assessed with Western blotting. Lane 1, 10 µmol/L rosiglitazone group; lane 2, 3 µmol/L rosiglitazone group; lane 3, control group.

Figure 3 Immunocytochemistry of rHSC-99 ×100. A: Positive of PPARγ in 10 µmol/L rosiglitazone group; B: positive of α-SMA in control group; C: weak positive of α-SMA in 10 µmol/L rosiglitazone group.